BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4975078)

  • 21. [Clinical usefulness of high-dose oral nitroglycerin in patients with stable angina pectoris].
    Kośmicki MA; Skorykow-Sapińska A; Sadowski Z
    Wiad Lek; 2003; 56(7-8):313-8. PubMed ID: 14969156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Peroral nitroglycerin preparations with long-term effect in angina pectoris].
    Falch J; Kjøller E
    Ugeskr Laeger; 1985 Jul; 147(28):2245-8. PubMed ID: 3933152
    [No Abstract]   [Full Text] [Related]  

  • 23. Nitroglycerin patches.
    Med Lett Drugs Ther; 1984 Jun; 26(664):59-60. PubMed ID: 6427567
    [No Abstract]   [Full Text] [Related]  

  • 24. [Serum nitrate levels in patients with stable angina pectoris treated with sustained-action nitroglycerin preparations].
    Halawa B; Mazurek W; Kuc K
    Wiad Lek; 1982 Jun; 35(7-8):451-5. PubMed ID: 6812289
    [No Abstract]   [Full Text] [Related]  

  • 25. Nitroglycerin prophylaxis in angina pectoris. Effect of sustained release nitroglycerin capsules on anginal frequency and exercise capacity.
    Davidov ME; Green AM
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2473-7. PubMed ID: 6775301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ergometric study of the duration of action of a delayed-action trinitrine in angina pectoris patients].
    Biour M; Yvenou L; Khireddine M; Gluck C; Parier JL; Cheymol G
    Therapie; 1988; 43(1):45-9. PubMed ID: 3128886
    [No Abstract]   [Full Text] [Related]  

  • 27. [Transdermal application of nitroglycerin in the treatment of angina pectoris].
    Koster RW
    Ned Tijdschr Geneeskd; 1985 Dec; 129(50):2389-90. PubMed ID: 3937062
    [No Abstract]   [Full Text] [Related]  

  • 28. Letter: Rapidity of action of stabilized nitroglycerin tablets.
    Greer B
    Am J Hosp Pharm; 1975 Oct; 32(10):979, 984. PubMed ID: 811116
    [No Abstract]   [Full Text] [Related]  

  • 29. [Long-term drug therapy of coronary disease (angina pectoris syndrome) in a health resort for heart diseases].
    Hammer O; Theissen W
    Z Allgemeinmed; 1972 Mar; 48(8):388-90. PubMed ID: 4624431
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hemodynamic effects of microencapsulated trinitrine].
    Groussin P
    Nouv Presse Med; 1975 Dec; 4(44):3139-40. PubMed ID: 815884
    [No Abstract]   [Full Text] [Related]  

  • 31. [Duration of the hemodynamic effect of various doses of delayed-action nitroglycerin preparations].
    Savvateev KL; Metelitsa VI; Vygodin VA
    Kardiologiia; 1983 Feb; 23(2):55-61. PubMed ID: 6405071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Transdermal nitroglycerin. Evaluation against a placebo in a double-blind multi-cross-over study].
    Dickstein K; Knutsen H
    Tidsskr Nor Laegeforen; 1985 Jun; 105(16):1139-42. PubMed ID: 3925590
    [No Abstract]   [Full Text] [Related]  

  • 33. [Relation of the anti-anginal effect of nitroglycerin and its blood level in patients with stable exertion-induced stenocardia].
    Metelitsa VI; Martsevich SIu; Blagodatskikh SV; Piotrovskiĭ VK; Riabokon' OS
    Kardiologiia; 1988 Oct; 28(10):10-4. PubMed ID: 3147338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superiority of verapamil to propranolol in stable angina pectoris: a double-blind, randomized crossover trail.
    Frishman WH; Klein NA; Strom JA; Willens H; LeJemtel TH; Jentzer J; Siegel L; Klein P; Kirschen N; Silverman R; Pollack S; Doyle R; Kirsten E; Sonnenblick EH
    Circulation; 1982 Jan; 65(1 Pt 2):I51-9. PubMed ID: 6796289
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nipentrol retard. Thoughts in connection with a new preparation].
    Naess K
    Tidsskr Nor Laegeforen; 1970 Aug; 90(16):1560-1. PubMed ID: 4989770
    [No Abstract]   [Full Text] [Related]  

  • 36. [Nitroglycerin dosage in the treatment of stenocardia].
    Gemke GR; Aleĭnikova MS
    Vrach Delo; 1971 Jun; (6):93-5. PubMed ID: 4999238
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison between alprenolol in tablet form (Aptin) and in "sustained release" form (Aptin Durules) in angina pectoris].
    Lorentzen F; Jorgensen P; Nielsen E; Nyberg G; Hvidt S
    Ugeskr Laeger; 1973 Jul; 135(27):1431-8. PubMed ID: 4585750
    [No Abstract]   [Full Text] [Related]  

  • 38. Metoprolol in angina pectoris complicated by essential hypertension. A clinical comparison of the antianginal efficacy of metoprolol slow-release tablets (Durules) given once daily and propranolol tablets given twice daily.
    BLoem TJ; Lindner PC
    Ann Clin Res; 1981; 13 Suppl 30():61-7. PubMed ID: 6794420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of Etafenon in angina pectoris. A clinical cougle-blind study].
    Lehmann HU; Hochrein H
    Med Klin; 1971 Nov; 66(46):1564-71. PubMed ID: 5002973
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effectiveness of using prolonged-action nitrates in ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1981 Sep; (9):24-7. PubMed ID: 6795823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.